Elysium Therapeutics' Grant

Elysium Therapeutics raised a round of funding on December 08, 2017. Investors include Ohio Third Frontier Commission.

Elysium Therapeutics has developed reformulated orally administered opioids so they can't be abused or cause overdose.…

Articles about Elysium Therapeutics' Grant: